These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21509786)

  • 1. Ensemble QSAR: a QSAR method based on conformational ensembles and metric descriptors.
    Pissurlenkar RR; Khedkar VM; Iyer RP; Coutinho EC
    J Comput Chem; 2011 Jul; 32(10):2204-18. PubMed ID: 21509786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How good are ensembles in improving QSAR models? The case with eCoRIA.
    Khedkar VM; Joseph J; Pissurlenkar R; Saran A; Coutinho EC
    J Biomol Struct Dyn; 2015; 33(4):749-69. PubMed ID: 24754910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3+3D-QSAR models.
    Martinek TA; Otvös F; Dervarics M; Tóth G; Fülöp F
    J Med Chem; 2005 May; 48(9):3239-50. PubMed ID: 15857130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-dimensional structure-activity relationship model to predict HIV-1 integrase strand transfer inhibition using LQTA-QSAR methodology.
    de Melo EB; Ferreira MM
    J Chem Inf Model; 2012 Jul; 52(7):1722-32. PubMed ID: 22657398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4D-QSAR analysis and pharmacophore modeling: electron conformational-genetic algorithm approach for penicillins.
    Yanmaz E; Sarıpınar E; Şahin K; Geçen N; Çopur F
    Bioorg Med Chem; 2011 Apr; 19(7):2199-210. PubMed ID: 21419636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic QSAR techniques: applications in drug design and toxicology.
    Mekenyan O
    Curr Pharm Des; 2002; 8(17):1605-21. PubMed ID: 12052203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protonation states and conformational ensemble in ligand-based QSAR modeling.
    De Benedetti PG
    Curr Pharm Des; 2013; 19(23):4323-9. PubMed ID: 23170884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a chirality-sensitive flexibility descriptor for 3+3D-QSAR.
    Dervarics M; Otvös F; Martinek TA
    J Chem Inf Model; 2006; 46(3):1431-8. PubMed ID: 16711763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
    Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
    J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional molecular descriptors and a novel QSAR method.
    Wildman SA; Crippen GM
    J Mol Graph Model; 2002 Dec; 21(3):161-70. PubMed ID: 12463634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
    Vistoli G; Pedretti A; Villa L; Testa B
    J Med Chem; 2005 Jul; 48(15):4947-52. PubMed ID: 16033273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling robust QSAR.
    Polanski J; Bak A; Gieleciak R; Magdziarz T
    J Chem Inf Model; 2006; 46(6):2310-8. PubMed ID: 17125174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New 3D amino acid structure descriptors and its application to the polypeptide QSAR].
    Ding JJ; Ding XQ; Zhao LF; Chen JS
    Yao Xue Xue Bao; 2005 Apr; 40(4):340-6. PubMed ID: 16011263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in QSAR and their applications in predicting the activities of chemical molecules, peptides and proteins for drug design.
    Du QS; Huang RB; Chou KC
    Curr Protein Pept Sci; 2008 Jun; 9(3):248-60. PubMed ID: 18537680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational sampling for large-scale virtual screening: accuracy versus ensemble size.
    Griewel A; Kayser O; Schlosser J; Rarey M
    J Chem Inf Model; 2009 Oct; 49(10):2303-11. PubMed ID: 19788252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. xMaP-An Interpretable Alignment-Free Four-Dimensional Quantitative Structure-Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles.
    Dreher J; Scheiber J; Stiefl N; Baumann K
    J Chem Inf Model; 2018 Jan; 58(1):165-181. PubMed ID: 29172519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of DAPPER for 3D QSAR: conformational search and chirality metric.
    Wildman SA; Crippen GM
    J Chem Inf Comput Sci; 2003; 43(2):629-36. PubMed ID: 12653531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on principles, theory and practices of 2D-QSAR.
    Roy K; Das RN
    Curr Drug Metab; 2014; 15(4):346-79. PubMed ID: 25204823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.